Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 31 of 95, showing 5 Applications out of 474 total, starting on record 151, ending on 155

# Protocol No Study Title Investigator(s) & Site(s)

151.

ECCT/21/11/02   SONIA Trial
    A Pragmatic Randomized Controlled Trial of Standard Care versus Steroids plus Standard Care for Treatment of Pneumonia in Adults Admitted to Kenyan Hospitals       
Principal Investigator(s)
1. Anthony Oliwa Etyang
2. Samuel Owuor Akech
Site(s) in Kenya
1. Kilifi County Hospital (Kilifi county)
2. Mbagathi Sub-county Hospital (Nairobi City county)
3. Busia County Referral Hospital (Busia county)
4. Bungoma County Referral Hospital (Bung\'oma county)
5. Kisumu County Hospital (Kisumu county)
6. Machakos Level 5 Hospital (Machakos county)
7. Mama Lucy Kibaki Hospital (Nairobi City county)
8. Kitale County Referral Hospital (Trans Nzoia county)
9. Kiambu County Hospital (Kiambu county)
10. Kakamega County Hospital (Kakamega county)
 
View

152.

ECCT/21/11/06   RESOLVE
    A Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy of Voxelotor for the Treatment of Leg Ulcers in Patients with Sickle Cell Disease    
Principal Investigator(s)
1. Videlis Nduba
Site(s) in Kenya
1. KEMRI/CRDR Siaya Clinical Research Annex (Siaya county)
2. KEMRI CRDR Clinical Research Clinic Nairobi (Nairobi City county)
 
View

153.

ECCT/21/09/06   The PrEDIRA Study
    PILOTING HIV PRE-EXPOSURE PROPHYLAXIS (PREP) INTEGRATION INTO SERVICES FOR EARLY PREGNANCY LOSS   
Principal Investigator(s)
1. Prof. Elizabeth Bukusi
2. Dr. Nelly Mugo
3. Renee Heffron
Site(s) in Kenya
1. KEMRI RCTP (Kisumu county)
2. PARTNERS IN HEALTH RESEARCH AND DEVELOPMENT - THIKA (Kiambu county)
 
View

154.

ECCT/21/11/04   GBT_131 Inclacumab-Ps 3 Trial.
    A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Safety and Efficacy of Inclacumab in Participants with Sickle Cell Disease Experiencing Vaso-occlusive Crises   
Principal Investigator(s)
1. Fredrick Sirwa Chite
2. Prof Jessie N Githanga
3. Bernhards Ragama Ogutu
4. Videlis N Nduba
Site(s) in Kenya
1. International Cancer Institute (ICI)-Eldorate (Uasin Gishu county)
2. KEMRI/CRDR (Nairobi City county)
3. KEMRI Siaya Clinical Research Annex (Siaya county)
4. Gertrude’s Children’s Hospital. (Nairobi City county)
5. Strathmore University Medical Centre (Nairobi City county)
 
View

155.

ECCT/21/09/04   Recombinant COVID-19 Vaccine
    A global multicenter, randomized, double-blind, placebo-controlled, phase III clinical trial to evaluate the efficacy, safety, and immunogenicity of recombinant COVID-19 vaccine (Sf9 cells) for the prevention of COVID-19 in adults aged 18 years and older            
Principal Investigator(s)
1. Sylvester Kimaiyo
Site(s) in Kenya
1. KAVI-Institute of Clinical Research (Nairobi City county)
2. Moi Teaching and Referral Hospital (Uasin Gishu county)
3. Kenya Medical Research Institute, Kilifi (Kilifi county)
 
View